Clinical trial

Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery

NCT00233974

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-05-01

PhasePHASE2

Study timeline

Study start (unknown)2002-05-01Date precision: month

Registry last updated2012-03-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

PET (positron emission tomography)PROCEDURE

Sponsors & collaborators

UNC Lineberger Comprehensive Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

Chapel HillNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00233974 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.